CD24
مجموعهٔ تمایزی ۲۴ (انگلیسی: Cluster of Differentiation 24) یا بهاختصار «CD24» که با عناوین دیگری همچون «مبدل سیگنال CD24» و «آنتیژن CD24 پایدار در حرارت» هم شناخته میشود، پروتئینی است که در انسان توسط ژن «CD24» کُد میشود.[۵] این پروتئین، یک «ملکول چسبندگی سلول» است.
این مولکول بر سطح لنفوسیتهای بی و نوروبلاستهای در حالِ تمایز بیان شده و تولید سیالوگلیکوپروتئین را سبب میشود.
منابع
- ↑ ۱٫۰ ۱٫۱ ۱٫۲ GRCh38: Ensembl release 89: ENSG00000272398 – Ensembl, May 2017
- ↑ ۲٫۰ ۲٫۱ ۲٫۲ GRCm38: Ensembl release 89: ENSMUSG00000047139 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Hough MR, Rosten PM, Sexton TL, Kay R, Humphries RK (July 1994). "Mapping of CD24 and homologous sequences to multiple chromosomal loci". Genomics. 22 (1): 154–61. doi:10.1006/geno.1994.1356. PMID 7959762.
- مشارکتکنندگان ویکیپدیا. «CD24». در دانشنامهٔ ویکیپدیای انگلیسی، بازبینیشده در ۱۷ دسامبر ۲۰۱۷.
جستارهای وابسته
- Li D, Zheng L, Jin L, et al. (2009). "CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection". Hepatology. 50 (3): 735–42. doi:10.1002/hep.23047. PMID 19610054.
- Piotrowski P, Lianeri M, Wudarski M, et al. (2010). "CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus". Tissue Antigens. 75 (6): HASH(0x2aadb3dd8b00). doi:10.1111/j.1399-0039.2010.01447.x. PMID 20230526.
- Honeth G, Bendahl PO, Ringnér M, et al. (2008). "The CD44+/CD24- phenotype is enriched in basal-like breast tumors". Breast Cancer Res. 10 (3): R53. doi:10.1186/bcr2108. PMC 2481503. PMID 18559090.
{{cite journal}}: نگهداری یادکرد:doi رایگان بینشان (رده) - Nagy B, Szendroi A, Romics I (2009). "Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy". Pathol. Oncol. Res. 15 (2): 279–83. doi:10.1007/s12253-008-9077-1. PMID 18752058.
- Kim KH, Choi JS, Kim JM, et al. (2009). "Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium". Histol. Histopathol. 24 (3): 309–16. PMID 19130400.
- Buess M, Rajski M, Vogel-Durrer BM, et al. (2009). "Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer". Neoplasia. 11 (10): 987–1002. PMC 2745665. PMID 19794958.
- Pruszak J, Ludwig W, Blak A, et al. (2009). "CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells". Stem Cells. 27 (12): 2928–40. doi:10.1002/stem.211. PMC 3322476. PMID 19725119.
- Liu Y, Chen GY, Zheng P (2009). "CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns". Trends Immunol. 30 (12): 557–61. doi:10.1016/j.it.2009.09.006. PMC 2788100. PMID 19786366.
- Vesuna F, Lisok A, Kimble B, Raman V (2009). "Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression". Neoplasia. 11 (12): 1318–28. PMC 2794513. PMID 20019840.
- Sagiv E, Arber N (2008). "The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy". Expert review of gastroenterology & hepatology. 2 (1): 125–33. doi:10.1586/17474124.2.1.125. PMID 19072375.
- Bauerschmitz GJ, Ranki T, Kangasniemi L, et al. (2008). "Tissue-specific promoters active in CD44+CD24-/low breast cancer cells". Cancer Res. 68 (14): 5533–9. doi:10.1158/0008-5472.CAN-07-5288. PMID 18632604.
- Carl JW, Liu JQ, Joshi PS, et al. (2008). "Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway". J. Immunol. 181 (1): 320–8. doi:10.4049/jimmunol.181.1.320. PMID 18566397.
- Baumhoer D, Riener MO, Zlobec I, et al. (2009). "Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater". Mod. Pathol. 22 (2): 306–13. doi:10.1038/modpathol.2008.192. PMID 19043399.
- Wang W, Wang X, Peng L, et al. (2010). "CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation". Cancer Sci. 101 (1): 112–9. doi:10.1111/j.1349-7006.2009.01370.x. PMID 19860845.
- Sano A, Kato H, Sakurai S, et al. (2009). "CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma". Ann. Surg. Oncol. 16 (2): 506–14. doi:10.1245/s10434-008-0252-0. PMID 19050962.
- Yang XR, Xu Y, Yu B, et al. (2009). "CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery". Clin. Cancer Res. 15 (17): 5518–27. doi:10.1158/1078-0432.CCR-09-0151. PMID 19706825.
- Lee JH, Kim SH, Lee ES, Kim YS (2009). "CD24 overexpression in cancer development and progression: a meta-analysis". Oncol. Rep. 22 (5): 1149–56. doi:10.3892/or_00000548. PMID 19787233.
- Gekara NO, Weiss S (2004). "Lipid rafts clustering and signalling by listeriolysin O". Biochem. Soc. Trans. 32 (Pt 5): 712–4. doi:10.1042/BST0320712. PMID 15493995.
- Athanassiadou P, Grapsa D, Gonidi M, et al. (2009). "CD24 expression has a prognostic impact in breast carcinoma". Pathol. Res. Pract. 205 (8): 524–33. doi:10.1016/j.prp.2009.01.008. PMID 19243896.
- Ronaghi M, Vallian S, Etemadifar M (2009). "CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population". Psychiatry Res. 170 (2–3): 271–2. doi:10.1016/j.psychres.2009.01.002. PMID 19896210.
پیوند به بیرون
- CD24 Antigen در سرعنوانهای موضوعی پزشکی (MeSH) در کتابخانهٔ ملی پزشکی ایالات متحدهٔ آمریکا
- مکان ژن انسانی CD24 در مرورگر ژنومی UCSC.
- جزئیات ژن انسانی CD24 در مرورگر ژنومی UCSC.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.